Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Revathi Suppiah"'
Autor:
Olsi Gjyshi, Pankaj Vashi, Laura Seewald, Mitra Kohan, Elham Abboud, Eric Fowler, Revathi Suppiah, Hatem Halabi
Publikováno v:
World Journal of Surgical Oncology, Vol 16, Iss 1, Pp 1-8 (2018)
Abstract Background Gastric cancer is the fifth most prevalent and the third most lethal cancer worldwide, causing approximately 720,000 deaths annually. Although most cases of gastric cancers are sporadic, one of its inherited forms, hereditary diff
Externí odkaz:
https://doaj.org/article/a5cbd15b9184465a93819bd073a5f8f3
A Case Report Demonstrating the Potential Clinical Relevance of Liquid Tumor Biopsies in Lung Cancer
Publikováno v:
Case Reports in Oncology, Vol 9, Iss 3, Pp 714-717 (2016)
A 50-year-old male with advanced non-small-cell lung cancer was unable to have standard-of-care molecular testing performed at diagnosis as a result of inadequacy of the available tissue. A subsequently performed commercial liquid tumor biopsy (Found
Externí odkaz:
https://doaj.org/article/d68da09772d74f1299c2c59f424c43c0
A Case Report Demonstrating the Potential Clinical Relevance of Liquid Tumor Biopsies in Lung Cancer
Publikováno v:
Case Reports in Oncology
Case Reports in Oncology, Vol 9, Iss 3, Pp 714-717 (2016)
Case Reports in Oncology, Vol 9, Iss 3, Pp 714-717 (2016)
A 50-year-old male with advanced non-small-cell lung cancer was unable to have standard-of-care molecular testing performed at diagnosis as a result of inadequacy of the available tissue. A subsequently performed commercial liquid tumor biopsy (Found
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2125b1bcb6da77d16f6bf1d9b2a476d
https://doi.org/10.1159/000450700
https://doi.org/10.1159/000450700
Publikováno v:
Laboratory Medicine. 38:109-115
A complicating feature of the myeloproliferative disorders is the frequent overlap of clinical, laboratory, and morphologic findings among the specific disorders. Cytogenetic and/or fluorescence in situ hybridization studies are performed to obtain e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c59b8bd3711b5ee541fb8f2580911b5
https://doi.org/10.1309/kl7d03x2ytye0pbb
https://doi.org/10.1309/kl7d03x2ytye0pbb
Autor:
Laura S. Wood, Slyvie Negrier, Ronald M. Bukowski, Steven Andresen, Paul Elson, Robert J. Motzer, Seema Misbah, Philip E. Shaheen, Revathi Suppiah
Publikováno v:
Cancer. 107:1793-1800
BACKGROUND. It has been suggested that thrombocytosis, as defined by a platelet count >400,000/μL, is a negative predictor for survival among patients with metastatic renal cell carcinoma. However, this has not been a uniform finding. METHODS. To ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a61058279b8f349509b687955a58725d
https://doi.org/10.1002/cncr.22237
https://doi.org/10.1002/cncr.22237
Publikováno v:
Clinical Lymphoma and Myeloma. 6:301-305
The design of innovative, more effective, less toxic therapy for multiple myeloma (MM) is emerging in parallel to a better understanding of the underlying pathophysiology of this common hematologic malignancy. Thalidomide has changed the treatment pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5739be8a41a6228d2a13500fb4490d90
https://doi.org/10.3816/clm.2006.n.004
https://doi.org/10.3816/clm.2006.n.004
Autor:
Rachid Baz, Steven Andresen, Janice Reed, Megan Kelly, Esteban Walker, Eric D. Hsi, Neeraj Agrawal, Revathi Suppiah, Beth Faiman, Mary Ann Karam, Gordan Srkalovic, Mohamad A. Hussein
Publikováno v:
Mayo Clinic proceedings. 81(7)
OBJECTIVE To evaluate the efficacy and safety of adding thalidomide to the pegylated liposomal doxorubicin, vincristine, and decreased-frequency dexamethasone (DVd) regimen for multiple myeloma. PATIENTS AND METHODS Patients newly diagnosed as having
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4e37e065a29e3907ec9b901ec17d7c0
https://pubmed.ncbi.nlm.nih.gov/16835966
https://pubmed.ncbi.nlm.nih.gov/16835966
Publikováno v:
Investigational new drugs. 24(6)
Based on reports of the efficacy of docetaxel (T) in STS, we undertook a phase I/II trial to determine the response rate (RR), dose-limiting toxicity (DLT), and maximum tolerated dose (MTD) of addition of T to doxorubicin (A) and ifosfamide (I) in ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e72c5d1819a1f750df5e4eab4bd0e887
https://pubmed.ncbi.nlm.nih.gov/16791410
https://pubmed.ncbi.nlm.nih.gov/16791410
Autor:
Revathi Suppiah, Matt Kalaycio
Publikováno v:
Leukemia & Lymphoma. 47:1149-1150
Hematologic malignancies are uncommon during the gestational period. The incidence of leukemia during pregnancy is estimated to be one per 75000 pregnancies [1]. Interferon, hydroxyurea and leukaph...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b934ecdc79917e2b1981079e14cdf59a
https://doi.org/10.1080/10428190500399029
https://doi.org/10.1080/10428190500399029
Autor:
Revathi Suppiah, Jorge A. Garcia, Robert Dreicer, James H. Finke, Brian I. Rini, Paul Elson, Laura S. Wood, Amy Richmond, Philip E. Shaheen, R. Bukowski
Publikováno v:
Journal of Clinical Oncology. 24:2526-2526
2526 Background: High numbers of regulatory T cells (Treg) and high expression of forkhead box transcription factor (FoxP3) in Treg are associated with decreased survival in various malignancies, likely via immunosuppression. Studies demonstrate Th1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c74083af219d1290cda50cf16b5fc568
https://doi.org/10.1200/jco.2006.24.18_suppl.2526
https://doi.org/10.1200/jco.2006.24.18_suppl.2526